- Home
- Publications
- Publication Search
- Publication Details
Title
Current and emerging therapeutic targets for IBD
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 14, Issue 5, Pages 269-278
Publisher
Springer Nature
Online
2017-02-01
DOI
10.1038/nrgastro.2016.208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice
- (2017) Vanessa Popp et al. GASTROENTEROLOGY
- Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
- (2016) A. Stallmach et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium
- (2016) Parambir S Dulai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases
- (2016) Hannah A. Blair et al. BIODRUGS
- Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases
- (2016) Emma D. Deeks BIODRUGS
- Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism
- (2016) I Oancea et al. GUT
- Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases
- (2016) Imke Atreya et al. Journal of Crohns & Colitis
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- Changes in Biosimilar Knowledge among European Crohn’s Colitis Organization [ECCO] Members: An Updated Survey
- (2016) Silvio Danese et al. Journal of Crohns & Colitis
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
- (2016) Julián Panés et al. LANCET
- Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
- (2016) David R Withers et al. NATURE MEDICINE
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
- (2016) Penelope Pelczar et al. SCIENCE
- Role and mechanisms of action ofEscherichia coliNissle 1917 in the maintenance of remission in ulcerative colitis patients: An update
- (2016) Franco Scaldaferri et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial
- (2016) Mariano García-Arranz et al. Stem Cells Translational Medicine
- Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy
- (2016) Julian Borchardt et al. Multiple Sclerosis and Related Disorders
- Late-breaking abstracts
- (2016) United European Gastroenterology Journal
- Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
- (2016) Kenji Suzuki et al. PLoS One
- Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis
- (2015) Prashant Nighot et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
- (2015) Melinda Gooderham et al. BIODRUGS
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease
- (2015) Paolo Biancheri et al. GASTROENTEROLOGY
- Allogeneic Bone Marrow–Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease
- (2015) Ilse Molendijk et al. GASTROENTEROLOGY
- Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study
- (2015) Walter Reinisch et al. GUT
- Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
- (2015) Robert V Bryant et al. GUT
- Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
- (2015) Anika Fischer et al. GUT
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
- (2015) Joseph R. Maxwell et al. IMMUNITY
- Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
- (2015) Reena Khanna et al. LANCET
- Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme
- (2015) Norbert Krug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
- (2015) Giovanni Monteleone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn’s disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact
- (2015) Rachele Ciccocioppo et al. Stem Cell Research & Therapy
- Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
- (2015) Derek C. Marshall et al. PLoS One
- Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis
- (2014) Stefanie Steiner et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
- (2014) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases
- (2014) Malgorzata Matusiewicz et al. DISEASE MARKERS
- Update on Janus Kinase Antagonists in Inflammatory Bowel Disease
- (2014) Brigid S. Boland et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
- (2014) Silvio Danese et al. GUT
- Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
- (2014) Tim Wyant et al. GUT
- Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studies
- (2014) Mindy CW Lam et al. Immunotherapy
- 6-Mercaptopurine Reduces Macrophage Activation and Gut Epithelium Proliferation Through Inhibition of GTPase Rac1
- (2014) Goran Marinković et al. INFLAMMATORY BOWEL DISEASES
- Inhibitors of phosphodiesterase 4 (PDE 4): A new therapeutic option in the treatment of psoriasis vulgaris and psoriatic arthritis
- (2014) Małgorzata Mazur et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells
- (2014) Katharina Gerlach et al. NATURE IMMUNOLOGY
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
- (2014) Raja Atreya et al. NATURE MEDICINE
- Adalimumab Induces Deep Remission in Patients With Crohn's Disease
- (2013) Jean–Frédéric Colombel et al. Clinical Gastroenterology and Hepatology
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
- (2013) Robert H. Oakley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism
- (2013) A Eken et al. Mucosal Immunology
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
- (2013) A. E. Dorofeyev et al. Gastroenterology Research and Practice
- Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
- (2012) I. Monteleone et al. CURRENT MOLECULAR MEDICINE
- Autologous Expanded Adipose-Derived Stem Cells for the Treatment of Complex Cryptoglandular Perianal Fistulas
- (2012) M.D. Herreros et al. DISEASES OF THE COLON & RECTUM
- Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
- (2012) Pierre Desreumaux et al. GASTROENTEROLOGY
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Mucosal healing in inflammatory bowel diseases: a systematic review
- (2012) Markus F Neurath et al. GUT
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohn's Disease
- (2011) Sergio Rutella et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Th17-related cytokines: new players in the control of chronic intestinal inflammation
- (2011) Ivan Monteleone et al. BMC Medicine
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
- (2011) Jean Frédéric Colombel et al. GASTROENTEROLOGY
- Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
- (2011) Raja Atreya et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- New therapies for inflammatory bowel disease: from the bench to the bedside
- (2011) Silvio Danese GUT
- Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change
- (2011) I. Ordas et al. GUT
- Toll-like receptor-7 ligand imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis
- (2011) Satheesh K. Sainathan et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
- (2011) Alessandra Geremia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Upregulated IL-7 Receptor Expression on Colitogenic Memory CD4+ T Cells May Participate in the Development and Persistence of Chronic Colitis
- (2011) T. Shinohara et al. JOURNAL OF IMMUNOLOGY
- Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
- (2011) Claudia Günther et al. NATURE
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Effects of TNF (TNFSF2) and IFN-γ on Intestinal Epithelial Cell Morphogenesis and Barrier Function in Three-Dimensional Culture
- (2011) Kati Juuti-Uusitalo et al. PLoS One
- Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
- (2010) Daniela De Nitto et al. CURRENT PHARMACEUTICAL DESIGN
- Phosphatidylcholine (Lecithin) and the Mucus Layer: Evidence of Therapeutic Efficacy in Ulcerative Colitis?
- (2010) Wolfgang Stremmel et al. DIGESTIVE DISEASES
- Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
- (2010) Anne Christine W. Vos et al. GASTROENTEROLOGY
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting the response to infliximab from trough serum levels
- (2009) P. Rutgeerts et al. GUT
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
- (2009) Geethanjali Pickert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation
- (2009) Amit Awasthi et al. NATURE IMMUNOLOGY
- F1C Fimbriae Play an Important Role in Biofilm Formation and Intestinal Colonization by the Escherichia coli Commensal Strain Nissle 1917
- (2008) M. A. Lasaro et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis
- (2008) Ashley J. Snider et al. FASEB JOURNAL
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
- (2008) Moritz Leppkes et al. GASTROENTEROLOGY
- IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
- (2008) T Kobayashi et al. GUT
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
- TGF-β1 and Smad7 in the regulation of IBD
- (2008) G Monteleone et al. Mucosal Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now